|
|
News Breaks
|
November 2, 2009
|
| 07:52 EDT |  | AEN |
| theflyonthewall.com: | Adeona Pharmaceuticals to start clinical trial for Zinthionein ZC-GS150 | | Adeona Pharmaceuticals announced that it has received Institutional Review Board approval to initiate a 60 patient, randomized, double-blind, placebo-controlled clinical trial of its patent pending Zinthionein ZC-GS150 in an Alzheimer's disease and mild cognitive impairment patient group. The clinical trial, titled "CopperProof 2," will test, for the first time, the effects of a novel gastro-retentive, sustained release zinc/cysteine combination tablet on the amelioration of sub-clinical zinc deficiency, and elevated percentage serum free copper, associated with Alzheimer's Disease. :theflyonthewall.com |
|
|
News For AEN From The Last 14 Days Check below for free stories on AEN the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 7, 2012
|
| 06:31 EDT | | AEN |
|
|
February 6, 2012
|
| 06:32 EDT | | AEN |
|
|
|
|
|
Subscribe for More Information